• Je něco špatně v tomto záznamu ?

Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor

A. Carazo, L. Hyrsova, J. Dusek, H. Chodounska, A. Horvatova, K. Berka, V. Bazgier, H. Gan-Schreier, W. Chamulitrat, E. Kudova, P. Pavek,

. 2017 ; 265 (-) : 86-96. [pub] 20161118

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013385

The Pregnane X (PXR), Vitamin D (VDR) and Farnesoid X (FXR) nuclear receptors have been shown to be receptors of bile acids controlling their detoxification or synthesis. Chenodeoxycholic (CDCA) and lithocholic (LCA) acids are ligands of FXR and VDR, respectively, whereas 3-keto and acetylated derivates of LCA have been described as ligands for all three receptors. In this study, we hypothesized that oxidation or acetylation at position 3, 7 and 12 of bile acids DCA (deoxycholic acid), LCA, CA (cholic acid), and CDCA by detoxification enzymes or microbiome may have an effect on the interactions with bile acid nuclear receptors. We employed reporter gene assays in HepG2 cells, the TR-FRET assay with recombinant PXR and RT-PCR to study the effects of acetylated and keto bile acids on the nuclear receptors activation and their target gene expression in differentiated hepatic HepaRG cells. We demonstrate that the DCA 3,12-diacetate and CA 3,7,12-triacetate derivatives are ligands of PXR and DCA 3,12-diacetate induces PXR target genes such as CYP3A4, CYP2B6 and ABCB1/MDR1. In conclusion, we found that acetylated DCA and CA are potent ligands of PXR. Whether the acetylated bile acid derivatives are novel endogenous ligands of PXR with detoxification or physiological functions should be further studied in ongoing experiments.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013385
003      
CZ-PrNML
005      
20170418110328.0
007      
ta
008      
170413s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.toxlet.2016.11.013 $2 doi
035    __
$a (PubMed)27871908
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
245    10
$a Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor / $c A. Carazo, L. Hyrsova, J. Dusek, H. Chodounska, A. Horvatova, K. Berka, V. Bazgier, H. Gan-Schreier, W. Chamulitrat, E. Kudova, P. Pavek,
520    9_
$a The Pregnane X (PXR), Vitamin D (VDR) and Farnesoid X (FXR) nuclear receptors have been shown to be receptors of bile acids controlling their detoxification or synthesis. Chenodeoxycholic (CDCA) and lithocholic (LCA) acids are ligands of FXR and VDR, respectively, whereas 3-keto and acetylated derivates of LCA have been described as ligands for all three receptors. In this study, we hypothesized that oxidation or acetylation at position 3, 7 and 12 of bile acids DCA (deoxycholic acid), LCA, CA (cholic acid), and CDCA by detoxification enzymes or microbiome may have an effect on the interactions with bile acid nuclear receptors. We employed reporter gene assays in HepG2 cells, the TR-FRET assay with recombinant PXR and RT-PCR to study the effects of acetylated and keto bile acids on the nuclear receptors activation and their target gene expression in differentiated hepatic HepaRG cells. We demonstrate that the DCA 3,12-diacetate and CA 3,7,12-triacetate derivatives are ligands of PXR and DCA 3,12-diacetate induces PXR target genes such as CYP3A4, CYP2B6 and ABCB1/MDR1. In conclusion, we found that acetylated DCA and CA are potent ligands of PXR. Whether the acetylated bile acid derivatives are novel endogenous ligands of PXR with detoxification or physiological functions should be further studied in ongoing experiments.
650    _2
$a acetylace $7 D000107
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné kultury $7 D018929
650    _2
$a kyselina cholová $x chemie $x metabolismus $x farmakologie $7 D019826
650    _2
$a cytochrom P450 CYP2B6 $x genetika $7 D065702
650    _2
$a cytochrom P-450 CYP3A $x genetika $7 D051544
650    _2
$a kyselina deoxycholová $x chemie $x metabolismus $x farmakologie $7 D003840
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a reportérové geny $7 D017930
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a hepatocyty $x účinky léků $x enzymologie $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a myši $7 D051379
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a P-glykoprotein $x genetika $7 D020168
650    _2
$a plazmidy $7 D010957
650    _2
$a vazba proteinů $7 D011485
650    _2
$a receptory kalcitriolu $x chemie $x genetika $x metabolismus $7 D018167
650    _2
$a receptory cytoplazmatické a nukleární $x chemie $x genetika $x metabolismus $7 D018160
650    _2
$a steroidní receptory $x chemie $x genetika $x metabolismus $7 D011987
650    _2
$a transfekce $7 D014162
650    _2
$a techniky dvojhybridového systému $7 D020798
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hyrsova, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
700    1_
$a Dusek, Jan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
700    1_
$a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo náměstí 2, CZ160 00 Praha, Czechia.
700    1_
$a Horvatova, Alzbeta $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia.
700    1_
$a Berka, Karel $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czechia.
700    1_
$a Bazgier, Vaclav $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky University in Olomouc, 17. listopadu 1131, Olomouc CZ779 00, Czechia.
700    1_
$a Gan-Schreier, Hongying $u Department of Internal Medicine IV, Gastroenterology and Infectious Diseases, Im Neuenheimer Feld, Heidelberg, Germany.
700    1_
$a Chamulitrat, Waleé $u Department of Internal Medicine IV, Gastroenterology and Infectious Diseases, Im Neuenheimer Feld, Heidelberg, Germany.
700    1_
$a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo náměstí 2, CZ160 00 Praha, Czechia.
700    1_
$a Pavek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University in Prague, Heyrovského 1203, Hradec Kralove CZ500 05, Czechia. Electronic address: petr.pavek@faf.cuni.cz.
773    0_
$w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 265, č. - (2017), s. 86-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27871908 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170418110636 $b ABA008
999    __
$a ok $b bmc $g 1199850 $s 974163
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 265 $c - $d 86-96 $e 20161118 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...